The Zacks Analyst Blog Highlights The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment
https://www.zacks.com/stock/news/2197286/the-zacks-analyst-blog-highlights-the-home-depot-advanced-micro-devices-pfizer-the-cigna-group-and-live-nation-entertainment?cid=CS-ZC-FT-press_releases-2197286
Dec 13, 2023 - The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment are part of the Zacks top Analyst Blog.
0
Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More
https://www.zacks.com/stock/news/2198513/pharma-stock-roundup-pfe-issues-weak-2024-view-azn-to-buy-icosavax-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2198513
Dec 15, 2023 - Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.
0
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
https://www.zacks.com/stock/news/2200049/pfizer-pfe-stock-rises-on-fda-nod-for-expanded-use-of-padcev?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200049
Dec 19, 2023 - The FDA approves Pfizer's (PFE) Padcev in combination with Merck's (MRK) Keytruda for adult patients with advanced bladder cancer. Stock rises 1.6%.
0
Pfizer (PFE) Flat As Market Sinks: What You Should Know
https://www.zacks.com/stock/news/2205278/pfizer-pfe-flat-as-market-sinks-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205278
Jan 03, 2024 - Pfizer (PFE) closed the most recent trading day at $29.73, making no change from the previous trading session.
0
Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
https://www.zacks.com/stock/news/2215849/merck-mrk-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2215849
Jan 25, 2024 - Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Markets Stroll Higher Ahead of Key Data; SMCI, FFIV, WHR Beat
https://www.zacks.com/stock/news/2217484/markets-stroll-higher-ahead-of-key-data-smci-ffiv-whr-beat?cid=CS-ZC-FT-ahead_of_wall_street-2217484
Jan 29, 2024 - A sixth record closing high for the S&P 500 just this month/year alone ought to give a good impression of where the market's collective head is at presently.
0
Home Prices Decreased in November
https://www.zacks.com/stock/news/2218065/home-prices-decreased-in-november?cid=CS-ZC-FT-economic_highlights-2218065
Jan 30, 2024 - Home Prices Decreased in November
0
GM Up on Q4 Beat & Raise; UPS, Pfizer Mixed
https://www.zacks.com/stock/news/2218048/gm-up-on-q4-beat-raise-ups-pfizer-mixed?cid=CS-ZC-FT-ahead_of_wall_street-2218048
Jan 30, 2024 - Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.
0
Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2218071/pfizer-pfe-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2218071
Jan 30, 2024 - While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214
Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.
0